Clinical Trial Update: Coreg CR, Blood Vessel Stiffness and Blood Vessel Function [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update for Coreg CR (carvedilol extended-release) evaluating blood vessel stiffness and endothelial function in patients with diabetes …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Endothelial Dysfunction
• Hypertension

Drugs mentioned

• COREG CR (carvedilol phosphate)

Snippet

Sponsor: State University of New York - Downstate Medical Center | Conditions: Endothelial Function, Diabetes Mellitus | Phase 4 | Status: UNKNOWN